Literature DB >> 6429710

Cost-benefit analysis of alternative programs of vaccination against rubella in Israel.

M Golden, G L Shapiro.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6429710     DOI： 10.1016/s0033-3506(84)80043-8

Source DB:  PubMed          Journal:  Public Health        ISSN： 0033-3506            Impact factor:   2.427


× No keyword cloud information.
  3 in total

Review 1.  Systematic review of the incremental costs of interventions that increase immunization coverage.

Authors:  Sachiko Ozawa; Tatenda T Yemeke; Kimberly M Thompson
Journal:  Vaccine       Date:  2018-05-10       Impact factor: 3.641

Review 2.  Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Authors:  Joseph B Babigumira; Ian Morgan; Ann Levin
Journal:  BMC Public Health       Date:  2013-04-29       Impact factor: 3.295

3.  Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo.

Authors:  Alvan Cheng; Kurt Frey; Guillaume Ngoie Mwamba; Kevin A McCarthy; Nicole A Hoff; Anne W Rimoin
Journal:  Vaccine X       Date:  2021-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.